Galmed Pharmaceuticals Ltd
GPH
Company Profile
Business description
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
Contact
c/o Meitar Law Offices, 16 Abba Hillel Road
Ramat Gan5250608
ISRT: +972 36938448
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
6
Stocks News & Analysis
stocks
World’s largest miner benefits from copper boom
Copper driven earnings growth underpins higher dividends and fair value upgrade.
stocks
ASX retailer sees weaker sales growth as conditions soften
Momentum fades as consumer spending softens.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,255.20 | 20.50 | 0.22% |
| CAC 40 | 8,501.91 | 7.45 | -0.09% |
| DAX 40 | 26,091.33 | 37.03 | -0.14% |
| Dow JONES (US) | 53,434.73 | 91.33 | 0.17% |
| FTSE 100 | 10,743.35 | 15.31 | 0.14% |
| HKSE | 25,495.07 | 23.92 | 0.09% |
| NASDAQ | 26,359.52 | 69.81 | 0.27% |
| Nikkei 225 | 65,326.42 | 2,134.30 | -3.16% |
| NZX 50 Index | 13,929.67 | 63.49 | 0.46% |
| S&P 500 | 7,718.26 | 26.50 | 0.34% |
| S&P/ASX 200 | 9,053.80 | 25.20 | 0.28% |
| SSE Composite Index | 3,894.42 | 95.88 | -2.40% |